Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
about
Current understanding of interactions between nanoparticles and the immune systemPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyFunctionally-interdependent shape-switching nanoparticles with controllable properties.Viral Vector-Mediated Antisense Therapy for Genetic Diseases.Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin.Cocoa Pod Husk Pectin Intended as a Pharmaceutical Excipient Has No Adverse Effects on Haematological Parameters in Sprague Dawley Rats.
P2860
Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunological and hematologica ...... cleic acid-based therapeutics.
@en
type
label
Immunological and hematologica ...... cleic acid-based therapeutics.
@en
prefLabel
Immunological and hematologica ...... cleic acid-based therapeutics.
@en
P2860
P1476
Immunological and hematologica ...... cleic acid-based therapeutics.
@en
P2093
Marina A Dobrovolskaia
Scott E McNeil
P2860
P304
P356
10.1517/14712598.2015.1014794
P407
P577
2015-05-28T00:00:00Z